$10.75 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Genetron

Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Stock Analysis

last close $10.75
1-mo return -20.6%
3-mo return -14.8%
avg daily vol. 178.83T
52-week high 31.54
52-week low 10.28
market cap. $1.1B
forward pe -
annual div. -
roe -18.9%
ltg forecast -
dividend yield -
annual rev. $478M
inst own. 22%

Subscribe now for daily local and international financial news